Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
India Ott
Institution:
AstraZeneca (United States)
Observed institution:
AstraZeneca (United States)
OpenAlex ID:
A5111084174
AZD4573 in Combination with CHOP Increases Combination Benefit in Preclinical Peripheral T-Cell Lymphomas Models
2023
·
Danielle S Potter
, India Ott
, et al.
·
Blood
·
3
Abstract 4605: AZD4573 in combination with CHOP increases combination benefit in preclinical peripheral T-cell lymphoma models
2024
·
Danielle Sinead Potter
, India Ott
, et al.
·
Cancer Research
Transient CDK9 Inhibition with AZD4573 Effectively Induces Apoptosis in Burkitt Lymphoma As a Monotherapy in Pre-Clinical Models
2023
·
Danielle S Potter
, India Ott
, et al.
·
Blood
Show more works
View as search
Works count:
3
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type